Grey Matters Raises CAD $800K in Mixed Equity-Debt Financing — Grey Matters Health Inc.

Event summary

Grey Matters Health Inc. raised CAD $800K through a private placement of CAD $500K in equity and CAD $300K in convertible debentures.
Equity units priced at CAD $0.40 each, including warrants exercisable at CAD $0.60.
Debentures carry 10% annual interest, convertible at CAD $0.455 per share, maturing in 24 months.
Proceeds earmarked for U.S. Alzheimer’s-focused neuroimaging clinics and working capital.
Offering expected to close by August 28, 2026.

The big picture

Grey Matters' hybrid financing reflects the capital-intensive nature of scaling specialized neuroimaging services, particularly in the U.S. where Alzheimer’s detection infrastructure remains fragmented. The mix of equity and debt suggests balancing immediate liquidity needs with longer-term growth ambitions, though the high interest rate (10%) on debentures signals investor caution. This raise comes as digital diagnostics gain traction, but competition from established players and reimbursement challenges loom.

What we're watching

Execution Risk: Whether Grey Matters can deploy capital efficiently to launch U.S. clinics amid competitive neuroimaging landscape.
Debt Dynamics: The pace at which convertible debentures may pressure equity dilution if converted early.
Regulatory Headwinds: How U.S. securities restrictions could complicate future cross-border fundraising efforts.